Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Clinical importance and therapeutic implication of E-cadherin gene methylation in human ovarian cancer.

Wu X, Zhuang YX, Hong CQ, Chen JY, You YJ, Zhang F, Huang P, Wu MY.

Med Oncol. 2014 Aug;31(8):100. doi: 10.1007/s12032-014-0100-y. Epub 2014 Jun 29.

PMID:
24973953
2.

[E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].

Qu PP, Shi Z, Li N.

Zhonghua Fu Chan Ke Za Zhi. 2009 Jul;44(7):538-41. Chinese.

PMID:
19957556
3.
4.

[Study on promoter methylation status of E-cadherin gene in nasopharyngeal carcinoma cell lines].

Hong CQ, Ran YG, Chen JY, Wu X, You YJ.

Zhonghua Bing Li Xue Za Zhi. 2010 Aug;39(8):532-6. Chinese.

PMID:
21055032
5.

Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.

Zhang H, Zhang S, Cui J, Zhang A, Shen L, Yu H.

Aust N Z J Obstet Gynaecol. 2008 Oct;48(5):505-9. doi: 10.1111/j.1479-828X.2008.00892.x.

PMID:
19032668
6.

RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines.

Zhang S, Wei L, Zhang A, Zhang L, Yu H.

OMICS. 2009 Aug;13(4):307-11. doi: 10.1089/omi.2009.0030.

PMID:
19645591
7.

Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.

Wang G, Hu X, Lu C, Su C, Luo S, Luo ZW.

Lung Cancer. 2008 Nov;62(2):162-72. doi: 10.1016/j.lungcan.2008.03.023. Epub 2008 May 12.

PMID:
18468719
8.

Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.

Wu Y, Zhang X, Lin L, Ma XP, Ma YC, Liu PS.

Asian Pac J Cancer Prev. 2014;15(3):1171-6.

9.

Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer.

Yuecheng Y, Hongmei L, Xiaoyan X.

Clin Exp Metastasis. 2006;23(1):65-74. Epub 2006 Jul 7.

PMID:
16826427
10.

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.

Wang N, Zhang H, Yao Q, Wang Y, Dai S, Yang X.

J Exp Clin Cancer Res. 2012 Jan 16;31:6. doi: 10.1186/1756-9966-31-6.

11.

Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.

Cheng JC, Auersperg N, Leung PC.

Oncogene. 2011 Sep 15;30(37):3930-42. doi: 10.1038/onc.2011.117. Epub 2011 Apr 11.

PMID:
21478913
12.

Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.

Zhou F, Tao G, Chen X, Xie W, Liu M, Cao X.

Clin Chem Lab Med. 2014 May;52(5):735-42. doi: 10.1515/cclm-2013-0736.

PMID:
24327526
13.

Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.

Wang Z, Li M, Lu S, Zhang Y, Wang H.

Cancer Biol Ther. 2006 Mar;5(3):256-60. Epub 2006 Mar 5.

PMID:
16418574
14.

XAF1 is frequently methylated in human esophageal cancer.

Chen XY, He QY, Guo MZ.

World J Gastroenterol. 2012 Jun 14;18(22):2844-9. doi: 10.3748/wjg.v18.i22.2844.

15.

[Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism].

Li M, Huang ZJ, Dong WH, Li XY, Wang XY, He XH, Wang H, Wang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jun;41(6):408-12. Chinese.

PMID:
16831366
16.
17.
18.

Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.

Balch C, Yan P, Craft T, Young S, Skalnik DG, Huang TH, Nephew KP.

Mol Cancer Ther. 2005 Oct;4(10):1505-14.

19.

Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.

Takada T, Yagi Y, Maekita T, Imura M, Nakagawa S, Tsao SW, Miyamoto K, Yoshino O, Yasugi T, Taketani Y, Ushijima T.

Cancer Sci. 2004 Sep;95(9):741-4.

20.

Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells.

Jacob F, Hitchins MP, Fedier A, Brennan K, Nixdorf S, Hacker NF, Ward R, Heinzelmann-Schwarz VA.

BMC Mol Biol. 2014 Oct 7;15:24. doi: 10.1186/1471-2199-15-24.

Supplemental Content

Support Center